Website
http://dataportal.arc.gov.au/NCGP/API/grants/FT230100559
Funding Status
Active
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Funded Activity Summary
Using ‘omic and digital technologies toward better fasciolosis control. In Australia, liver fluke disease caused by Fasciola hepatica causes major economic losses to livestock production. Triclabendazole is the most effective drug for parasite control, however, resistance to this drug has emerged and continues to spread in Australia. This project expects to create a novel resource to identify new drug targets, generate new knowledge about the genetic composition of F. hepatica populations and unravel the genetic determinants underlying triclabendazole resistance. The curation of functionally-annotated genetic data for F. hepatica populations will underpin the development of diagnostic tests, drugs and vaccines to deliver a new generation of intervention strategies to control liver fluke disease.Funded Activity Details
Start Date: 07-2023
End Date: 06-2027
Funding Scheme: ARC Future Fellowships
Funding Amount: $949,006.00
Funder: Australian Research Council
Research Topics
ANZSRC Field of Research (FoR)
Veterinary parasitology | Genomics and transcriptomics | Computational ecology and phylogenetics | Veterinary sciences
ANZSRC Socio-Economic Objective (SEO)
